These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 1532962

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder.
    Rapoport JL, Ryland DH, Kriete M.
    Arch Gen Psychiatry; 1992 Jul; 49(7):517-21. PubMed ID: 1385694
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Clinical overview of serotonin reuptake inhibitors.
    Rickels K, Schweizer E.
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():9-12. PubMed ID: 2147922
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
    Barr LC, Goodman WK, Anand A, McDougle CJ, Price LH.
    Am J Psychiatry; 1997 Sep; 154(9):1293-5. PubMed ID: 9286191
    [Abstract] [Full Text] [Related]

  • 29. Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents.
    Murphy DL, Pato MT, Pigott TA.
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):91S-100S. PubMed ID: 1973944
    [Abstract] [Full Text] [Related]

  • 30. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania.
    Stein DJ, Hollander E.
    J Clin Psychiatry; 1992 Apr; 53(4):123-6. PubMed ID: 1532960
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Biological treatments in obsessive-compulsive disorder].
    Montgomery SA, Fineberg NA, Montgomery D.
    Encephale; 1990 Apr; 16 Spec No():335-9. PubMed ID: 2209492
    [Abstract] [Full Text] [Related]

  • 34. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
    McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR.
    J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
    [Abstract] [Full Text] [Related]

  • 35. Intravenous anti-obsessive agents: a review.
    Ravindran LN, Jung SM, Ravindran AV.
    J Psychopharmacol; 2010 Mar; 24(3):287-96. PubMed ID: 18801828
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pica and the obsessive-compulsive spectrum disorders.
    Stein DJ, Bouwer C, van Heerden B.
    S Afr Med J; 1996 Dec; 86(12 Suppl):1586-8, 1591-2. PubMed ID: 9180801
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.